Compare Fox Corp Class B (FOX) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fox Corp Class B vs Hinge Health Inc. Class A Common Stock — how do they compare? Fox Corp Class B trades at $55.56 (market cap $24.79B), while Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B). The key difference: Fox Corp Class B is far larger — about 2.9× Hinge Health Inc. Class A Common Stock's market cap, and Fox Corp Class B pays a 1.04% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fox Corp Class B for 75 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| FOX | HNGE | |
|---|---|---|
Market Cap | $24.79B | $8.47B |
Volume | 707,876 | 1,624,526 |
Sector | Media | Health |
52-Week High | $67.76 | $105.14 |
52-Week Low | $44.39 | $31.17 |
Typical Hold Time | 75 Days | 0 Days |
Enterprise Value | $28.16B | $8.09B |
Dividend Yield | 1.04% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FOX trades at $55.93, down 0.09% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.79 beating expectations of $1.44, and fundamentals show robust revenue growth to $16.30 billion in 2025 and a net income margin of 13.88%. Analyst consensus is a buy with a price target of $84.75, implying significant upside. A dividend of $0.29 per share is scheduled for payment on September 23, 2026.
The outlook for FOX is positive based on solid fundamentals and analyst optimism, but risks include a projected decline in net income margin to 9.83% in 2026 and bearish technical indicators. The stock offers value with a P/E of 14.56 and growth potential, though investors should monitor earnings consistency and market sentiment shifts.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Fox Corp Class B
Fox represents the assets not sold to Disney by the predecessor firm, Twenty First Century Fox. The remaining assets include Fox News, the FOX broadcast network, FS1 and FS2, Fox Business, Big Ten Network, 28 owned and operated local television stations of which 17 are affiliated with the Fox Network, and the Fox Studios lot. The Murdoch family continues to control the successor firm, which represents a large-scale bet on the value of live sports and news in the U.S. market.
Read more on FOX →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
